Taipei, Chinese Imposes Inulin Use Restrictions and Labeling Requirements

Taipei, Chinese has established use restrictions and labeling requirements for inulin produced by fructosyltransferase when used as a food ingredient, ensuring consumer transparency and safety.

Compliance Answer: Use Restrictions and Labeling Requirements for Inulin Produced by Fructosyltransferase in Chinese Taipei

Direct Answer

Chinese Taipei has proposed a draft regulation to establish use restrictions and labeling requirements for inulin produced by fructosyltransferase (derived from Bacillus sp. strain 217C-11) when used as a food ingredient. The regulation aims to ensure food safety and consumer transparency under the Act Governing Food Safety and Sanitation¹. Key requirements include specific labeling disclosures and potential use limitations, though exact provisions (e.g., permissible concentrations, prohibited food categories) are not yet finalized in the draft^{1, 2}.

Regulation Analysis

1. Legal Basis and Objective

• The draft regulation is grounded in the Act Governing Food Safety and Sanitation, which mandates safety assessments and labeling for novel food ingredients¹.
• Primary objective: Protection of human health by ensuring the safe use of inulin produced via enzymatic synthesis (fructosyltransferase) and preventing misleading claims^{1, 2}.
• No international standard conformity: The draft does not align with Codex Alimentarius or other international standards, as none exist for this specific ingredient².

2. Scope and Coverage

• Product: Inulin produced by fructosyltransferase derived from Bacillus sp. strain 217C-11^{1, 2}.
• Application: Used as a food ingredient in general food products (ICS code: 67.040)¹.
• Geographic scope: Applies to all food products marketed in Chinese Taipei, regardless of origin (domestic or imported)².

3. Key Requirements (Draft Provisions)

While the draft regulation specifies the need for use restrictions and labeling requirements, the exact details (e.g., maximum usage levels, prohibited food categories, or mandatory labeling phrases) are not publicly disclosed in the provided sources. However, the following obligations are implied or referenced:

4. Labeling Requirements

• The draft mandates specific labeling for inulin produced by fructosyltransferase, though the exact wording is not provided in the sources. Likely requirements may include:
  • Disclosure of the enzymatic production method (e.g., "inulin produced by fructosyltransferase")¹.
  • Source organism (e.g., Bacillus sp. strain 217C-11)¹.
  • Functional claims (if any) must be substantiated and not misleading¹.
• Language: Labeling must comply with Chinese Taipei’s official language requirements (Chinese and/or English, depending on the product’s target market)¹.

5. Use Restrictions

• The draft may impose quantitative or qualitative limits on the use of inulin produced by fructosyltransferase, such as:
  • Maximum permissible levels in specific food categories (e.g., infant formula, beverages)¹.
  • Prohibited uses in certain foods (e.g., those with existing safety concerns)¹.
• Note: Specific restrictions are not detailed in the provided sources and will be finalized upon adoption^{1, 2}.

6. Compliance Timeline and Stakeholder Engagement

• Comment Period: Stakeholders might submit feedback until 9 March 2026 (60 days from notification)^{1, 2}.
• Adoption and Enforcement:
  • Proposed adoption date: To be determined^{1, 2}.
  • Entry into force: Likely 6 months after publication in the Official Government Gazette, though this is not confirmed¹.
• Enforcement Authority: Food and Drug Administration (FDA), Ministry of Health and Welfare¹.

7. Relevant Documents and Contacts

• Draft Text: Available in Chinese and English via the WTO TBT/SPS notifications^{1, 2}:
  • ¹(https://members.wto.org/crnattachments/2026/TBT/TPKM/26_00124_00_x.pdf)
  • ¹(https://members.wto.org/crnattachments/2026/TBT/TPKM/26_00124_00_e.pdf)
• Official Publication: Will be published in the Official Government Gazette post-adoption¹.
• Contact for Comments:
  • WTO TBT Enquiry Point:

Email: `tbtenq@bsmi.gov.tw` Tel: +(886-2) 23431700#1566¹.

• Animal and Plant Health Inspection Agency (APHIA):

Email: `wtosps@aphia.gov.tw` Website:²(http://www.aphia.gov.tw/)².

Summary Answer

Chinese Taipei’s draft regulation imposes use restrictions and labeling requirements for inulin produced by fructosyltransferase (derived from Bacillus sp. strain 217C-11) as a food ingredient, pursuant to the Act Governing Food Safety and Sanitation¹. Key obligations include:

1. Labeling: Mandatory disclosure of the production method and source organism¹.
2. Use Restrictions: Potential limits on dosage or food categories, though specifics are pending finalization^{1, 2}.
3. Compliance Timeline: Stakeholders may submit comments until 9 March 2026, with enforcement expected 6 months post-publication¹.

The regulation aims to ensure food safety and transparency but does not conform to any existing international standard². For definitive requirements, stakeholders should monitor updates from the Food and Drug Administration or the WTO TBT Enquiry Point^{1, 2}.

Sources

1. ↩ Draft for the Use Restrictions and Labeling Requirements of Inulin Produced by Fructosyltransferase as a Food Ingredient https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=Q:/G/TBTN26/TPKM586.pdf&Open=True
2. ↩ Draft for the Use Restrictions and Labeling Requirements of Inulin Produced by Fructosyltransferase as a Food Ingredient https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=Q:/G/SPS/NTPKM654.pdf&Open=True